Welcome
Support Centre
21 November 2008 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
UKCTG
mental health register
archived registers
all registers
tips on searching
 
Registration
submit trials
 
Information
about mRCT
mRCT FAQs
data items
memorandum
contributors

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
A comparative study of static magnetic field (SMF) therapy against Transcutaneous Electrical Nerve Stimulation (TENS) therapy on mechanical back pain and neck pain.
Source of recordUK Clinical Trials Gateway
ISRCTNISRCTN56847801
Date ISRCTN assigned30/09/2004
Local reference number(s)N0355127318
Public titleA comparative study of static magnetic field (SMF) therapy against Transcutaneous Electrical Nerve Stimulation (TENS) therapy on mechanical back pain and neck pain.
Scientific title
AcronymN/A
Disease/condition/study domainMusculoskeletal Diseases: Back pain
Study hypothesisThe project aims to identify
1. The efficacy of magnet therapy for treating chronic mechanical back and neck pain
2. The efficacy of magnet therapy against traditional TENS therapy for treating chronic mechanical back and neck pain
Hypothesis: Using magnetic therapy will decrease pain and improve quality of life, sleep, reduce analgesic intake more than traditional TENS therapy on mechanical back and neck pain.
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteria1. Chronic pain consultants referrals only
2. Patients normally eligible for TENS therapy
3. Ability to understand simple instructions
4. Ability to apply therapies by self/significant other
5. Patients with a diagnosis of mechanical back or neck pain only (no neurological deficits)
Participants - exclusion criteria1. Patients who have a pacemaker
2. Have intracranial clips/aneurysms
3. Would not be able to apply therapies by self or have no help for applying
5. Are outside the age range
6. Are pregnant or may be trying to get pregnant

Reasons include: magnets can increase the failure of pacemakers, having metal work within the head area. Pregnancy: magnets may be harmful to the unborn child (although it hasn¿t been clinically proven).
Patient information material
Anticipated start date01/08/2003
Anticipated end date30/04/2004
Status of trialCompleted
Target number of participantsNot provided at time of registration
InterventionsPatients referred via the 3 chronic pain consultants will be entered into the study if fitting the inclusion criteria. Twenty-five for TENS and 25 for magnet therapy. A trial of two therapies: conventional TENS using a programmable machine and a specific programme for 2 hours 3 times a day or a magnetic belt which will work continuously between rising and bedtime. They will be randomly selected for a trial of a TENS machine or magnetic belt for a period of 6 weeks. There will be a week¿s window before the cross-over therapy for a further 6 weeks. At each completion of the therapy a short evaluation questionnaire will be completed. Normal analgesics can be continued throughout the trial but they are advised that if they receive benefit from the therapy they can reduce their analgesic intake.
Primary outcome measure(s)We have developed a short questionnaire to be completed at the end of each therapy to identify if there has been any change in the pain or their behaviour. We are looking for differences in:
1. Level of pain
2. Functional activity
3. Medication reduction
4. Sleep activity
5. Quality of Life
Each section can score a maximum of 20, the lowest number of 0 being the best outcome. The total of all sections are calculated to a maximum of 100. The higher the score the worse the outcome.
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingMid Essex Hospital Services NHS Trust
Sponsor nameRecord Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
Sponsor detailsThe Department of Health, Richmond House, 79 Whitehall
London
United Kingdom
SW1A 2NL
Sponsor telephone+44 (0)20 7307 2622
Sponsor emaildhmail@doh.gsi.org.uk
Sponsor websitehttp://www.dh.gov.uk/Home/fs/en
Contact nameMs Karen MacKrodt
Contact detailsMid Essex Hospital Services NHS Trust
Broomfield Hospital


Chelmsford
United Kingdom
CM1 7ET
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN56847801
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
terms & conditions | privacy statement | © Current Controlled Trials Ltd


BioMed Central